Seema Dawood: Why Some Red Cells Break While Others Survive?
Seema Dawood, Medical Laboratory Technologist at The Aga Khan University Hospital, shared a post on LinkedIn:
“Why do some red cells pop early and others hang on?
The osmotic fragility test tells you.
Drop a red blood cell into water and watch what happens: normal cells swell, stretch, and just hold together, thanks to their biconcave shape acting like a built-in reserve tank. Spherocytes don’t get that luxury.
Osmotic Fragility Test: Principle and Procedure
The osmotic fragility test evaluates the susceptibility of red blood cells to hemolysis when exposed to varying concentrations of hypotonic saline. It’s a key tool in diagnosing conditions like hereditary spherocytosis and other membrane disorders.
Principle:
- Normal RBCs can withstand mild hypotonic stress by swelling before lysing, due to their biconcave shape offering surface area reserve.
- Spherocytes, having lost this reserve, hemolyze at higher saline concentrations (increased fragility).
- Conversely, cells like target cells (seen in thalassemia) show decreased fragility.
Method:
Prepare a series of test tubes with buffered saline solutions ranging from 0.9% (isotonic) down to 0.0% (distilled water), typically in graded steps (e.g., 0.1% increments).
Add a fixed volume of fresh anticoagulated blood to each tube.
- Mix gently and incubate at room temperature for 30 minutes.
- Centrifuge the tubes.
- Examine the supernatant for hemolysis visually or by measuring absorbance spectrophotometrically (540 nm).
- Calculate the percentage hemolysis at each saline concentration and plot against concentration to generate a fragility curve.
- Compare against a normal control run in parallel.
Interpretation:
- Increased fragility: hereditary spherocytosis, autoimmune hemolytic anemia
- Decreased fragility: thalassemia, iron deficiency anemia, liver disease
- A simple, low-cost test that still holds diagnostic value alongside newer methods like EMA binding and flow cytometry.”
Other posts featuring Seema Dawood on Hemostasis Today.
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics